Li H, Qiao L, Kong M, Fang H, Yan Z, Guo R
Sci Rep. 2024; 14(1):26994.
PMID: 39506070
PMC: 11541849.
DOI: 10.1038/s41598-024-78467-3.
Garg R, Williamson M
BMC Cancer. 2024; 24(1):1004.
PMID: 39138404
PMC: 11321201.
DOI: 10.1186/s12885-024-12762-0.
Peng H, Yang M, Feng K, Lv Q, Zhang Y
Signal Transduct Target Ther. 2024; 9(1):169.
PMID: 38956074
PMC: 11220018.
DOI: 10.1038/s41392-024-01887-0.
Iniguez-Munoz S, Llinas-Arias P, Ensenyat-Mendez M, Bedoya-Lopez A, Orozco J, Cortes J
Cell Mol Life Sci. 2024; 81(1):274.
PMID: 38902506
PMC: 11335195.
DOI: 10.1007/s00018-024-05314-z.
Tam K, Liu L, Hsing M, Dalal K, Thaper D, McConeghy B
Sci Rep. 2024; 14(1):7082.
PMID: 38528115
PMC: 10963789.
DOI: 10.1038/s41598-024-57854-w.
Long non-coding RNA lung cancer-associated transcript-1 promotes glioblastoma progression by enhancing Hypoxia-inducible factor 1 alpha activity.
Huang H, Shah H, Hao J, Lin J, Prayson R, Xie L
Neuro Oncol. 2024; 26(8):1388-1401.
PMID: 38456228
PMC: 11300024.
DOI: 10.1093/neuonc/noae036.
The semaphorin 3A/neuropilin-1 pathway promotes clonogenic growth of glioblastoma via activation of TGF-β signaling.
Jeon H, Shin Y, Lee J, Chang N, Woo D, Lee W
JCI Insight. 2023; 8(21.
PMID: 37788099
PMC: 10721275.
DOI: 10.1172/jci.insight.167049.
Association between circ_0004365 and cisplatin resistance in esophageal squamous cell carcinoma.
Yamada M, Tanaka K, Yamamoto K, Matsumoto H, Yamasaki M, Yamashita K
Oncol Lett. 2023; 26(5):467.
PMID: 37780544
PMC: 10534278.
DOI: 10.3892/ol.2023.14054.
Plexins as Regulators of Cancer Cell Proliferation, Migration, and Invasivity.
Toledano S, Neufeld G
Cancers (Basel). 2023; 15(16).
PMID: 37627074
PMC: 10452846.
DOI: 10.3390/cancers15164046.
A novel EGFR variant EGFRx maintains glioblastoma stem cells through STAT5.
Huang W, Li J, Zhu H, Qin X, Chen C, Wang B
Neuro Oncol. 2023; 26(1):85-99.
PMID: 37616578
PMC: 10768976.
DOI: 10.1093/neuonc/noad153.
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma.
Hao J, Han X, Huang H, Yu X, Fang J, Zhao J
Nat Commun. 2023; 14(1):2262.
PMID: 37080989
PMC: 10119166.
DOI: 10.1038/s41467-023-37397-w.
Plexin-A2 enables the proliferation and the development of tumors from glioblastoma derived cells.
Toledano S, Sabag A, Ilan N, Liburkin-Dan T, Kessler O, Neufeld G
Cell Death Dis. 2023; 14(1):41.
PMID: 36658114
PMC: 9852426.
DOI: 10.1038/s41419-023-05554-0.
Extracellular vesicles in the glioblastoma microenvironment: A diagnostic and therapeutic perspective.
Russo M, Whaley L, Norton E, Zarco N, Guerrero-Cazares H
Mol Aspects Med. 2022; 91:101167.
PMID: 36577547
PMC: 10073317.
DOI: 10.1016/j.mam.2022.101167.
From protein-protein interactions to immune modulation: Therapeutic prospects of targeting Neuropilin-1 in high-grade glioma.
Smith G, Radin D, Tsirka S
Front Immunol. 2022; 13:958620.
PMID: 36203599
PMC: 9532003.
DOI: 10.3389/fimmu.2022.958620.
Hypoxia-induced HMGB1 promotes glioma stem cells self-renewal and tumorigenicity via RAGE.
Ye C, Li H, Li Y, Zhang Y, Liu G, Mi H
iScience. 2022; 25(9):104872.
PMID: 36034219
PMC: 9399482.
DOI: 10.1016/j.isci.2022.104872.
SEMA3C Supports Pancreatic Cancer Progression by Regulating the Autophagy Process and Tumor Immune Microenvironment.
Zhang D, Lindstrom A, Kim E, Hwang C, Hall M, Lin T
Front Oncol. 2022; 12:890154.
PMID: 35785187
PMC: 9243227.
DOI: 10.3389/fonc.2022.890154.
Cross-species single-cell transcriptomic analysis reveals divergence of cell composition and functions in mammalian ileum epithelium.
Li H, Wang X, Wang Y, Zhang M, Hong F, Wang H
Cell Regen. 2022; 11(1):19.
PMID: 35511361
PMC: 9072607.
DOI: 10.1186/s13619-022-00118-7.
Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas.
Zhang P, Liu G, Hu J, Chen S, Wang B, Peng P
Front Immunol. 2022; 13:824586.
PMID: 35371015
PMC: 8966496.
DOI: 10.3389/fimmu.2022.824586.
Evaluation of Comprehensive Gene Expression and NK Cell-Mediated Killing in Glioblastoma Cell Line-Derived Spheroids.
Morimoto T, Nakazawa T, Matsuda R, Nishimura F, Nakamura M, Yamada S
Cancers (Basel). 2021; 13(19).
PMID: 34638384
PMC: 8508082.
DOI: 10.3390/cancers13194896.
Opportunities and challenges of glioma organoids.
Xu X, Li L, Luo L, Shu L, Si X, Chen Z
Cell Commun Signal. 2021; 19(1):102.
PMID: 34635112
PMC: 8504127.
DOI: 10.1186/s12964-021-00777-0.